Amneal Pharmaceuticals, Inc. (AMRX)
Data as of , from SEC Form 4 filings.
See up to 3 months of AMRX. The 7-day demo opens the 1M and 3M ranges and puts AMRX on your watchlist.
Start 7-day demoLatest AMRX insider trades
About Amneal Pharmaceuticals, Inc. (AMRX)
Amneal Pharmaceuticals, Inc. files with the SEC under CIK 0001723128 and is classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
AMRX Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 4 | 413,016 | $7.22M |
| Grant or award | 4 | 25,810,569 | |
| Option exercise | 3 | 209,463 | |
AMRX insider transactions (Form 4)
12251 Form 4 filings on record, the earliest from Nov 19, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| J. Kevin Buchi - Director | Gift | Class A Common Stock | 20,445 | $0.00 | - | |
| J. Kevin Buchi - Director | Option exercise | Class A Common Stock | 20,445 | $14.45 | $295K | |
| J. Kevin Buchi - Director | Option exercise | Stock Option | 20,445 | $0.00 | - | |
| Gift | Class A Common Stock | 80,000 | $0.00 | - | ||
| Gift | Class A Common Stock | 152,426 | $0.00 | - | ||
| John Kiely - Director | Open-market sale | Class A Common Stock | 50,000 | $17.64 footnote F1 | $882K | |
| John Kiely - Director | Gift | Class A Common Stock | 10,000 | $0.00 footnote F2 | - | |
| ||||||
| Nikita Shah - Officer | Open-market sale | Class A Common Stock | 146,403 | $17.51 footnote F1 | $2.56M | |
| ||||||
| Jason B. Daly - Officer | Open-market sale | Class A Common Stock | 6,613 | $17.70 footnote F1 | $117K | |
| Jason B. Daly - Officer | Open-market sale | Class A Common Stock | 210,000 | $17.40 footnote F2 | $3.65M | |
| ||||||
| J. Kevin Buchi - Director | Option exercise | Class A Common Stock | 168,573 | $17.18 footnote F1 | $2.90M | |
| ||||||
| Tushar Bhikhubhai Patel - 10% Owner | Grant or award | Class A Common Stock | 12,763,469 | - footnote F1 | - | |
| ||||||
| Chintu Patel - Officer | Grant or award | Class A Common Stock | 6,381,734 | - footnote F1 | - | |
| ||||||
| Gautam Patel - Director | Grant or award | Class A Common Stock | 283,632 | - footnote F1 | - | |
| ||||||
| Grant or award | Class A Common Stock | 6,381,734 | - footnote F1 | - | ||
| ||||||
| Deborah M. Autor - Director | Open-market sale | Class A Common Stock | 34,819 | $12.94 footnote F1 | $451K | |
| ||||||
| J. Kevin Buchi - Director | Option exercise | Class A Common Stock | 34,819 | - footnote F1 | - | |
| J. Kevin Buchi - Director | Option exercise | Restricted Stock Units | 34,819 | $0.00 | - | |
| J. Kevin Buchi - Director | Grant or award | Restricted Stock Units | 19,824 | $0.00 | - | |
| ||||||
| Deborah M. Autor - Director | Option exercise | Class A Common Stock | 34,819 | - footnote F1 | - | |
| Deborah M. Autor - Director | Option exercise | Restricted Stock Units | 34,819 | $0.00 | - | |
| Deborah M. Autor - Director | Grant or award | Restricted Stock Units | 19,824 | $0.00 | - | |
| ||||||
| Option exercise | Class A Common Stock | 34,819 | - footnote F1 | - | ||
| Option exercise | Restricted Stock Units | 34,819 | $0.00 | - | ||
| Grant or award | Restricted Stock Units | 19,824 | $0.00 | - | ||
| ||||||
| Gautam Patel - Director | Option exercise | Class A Common Stock | 34,819 | - footnote F1 | - | |
| Gautam Patel - Director | Option exercise | Restricted Stock Units | 34,819 | $0.00 | - | |
| Gautam Patel - Director | Grant or award | Restricted Stock Units | 19,824 | $0.00 | - | |
| ||||||
| John Kiely - Director | Option exercise | Class A Common Stock | 34,819 | - footnote F1 | - | |
| John Kiely - Director | Option exercise | Restricted Stock Units | 34,819 | $0.00 | - | |
| John Kiely - Director | Grant or award | Restricted Stock Units | 19,824 | $0.00 | - | |
| ||||||
| Ted C. Nark - Director | Option exercise | Class A Common Stock | 34,819 | - footnote F1 | - | |
| Ted C. Nark - Director | Option exercise | Restricted Stock Units | 34,819 | $0.00 | - | |
| Ted C. Nark - Director | Grant or award | Restricted Stock Units | 19,824 | $0.00 | - | |
| ||||||
| Paul M. Meister - Director | Option exercise | Class A Common Stock | 48,747 | - footnote F1 | - | |
| Paul M. Meister - Director | Option exercise | Restricted Stock Units | 48,747 | $0.00 | - | |
| Paul M. Meister - Director | Grant or award | Restricted Stock Units | 30,837 | $0.00 | - | |
| ||||||
| Shlomo Yanai - Director | Option exercise | Class A Common Stock | 34,819 | - footnote F1 | - | |
| Shlomo Yanai - Director | Option exercise | Restricted Stock Units | 34,819 | $0.00 | - | |
| Shlomo Yanai - Director | Grant or award | Restricted Stock Units | 19,824 | $0.00 | - | |
| ||||||
| Chintu Patel - Officer | Grant or award | Performance-Based Restricted Stock Units | 544,663 | $0.00 | - | |
| Grant or award | Performance-Based Restricted Stock Units | 544,663 | $0.00 | - | ||
| Chintu Patel - Officer | Tax withholding / forfeiture | Class A Common Stock | 28,983 footnote F3 | $13.30 | $385K | |
| Chintu Patel - Officer | Option exercise | Restricted Stock Units | 59,931 | $0.00 | - | |
| Chintu Patel - Officer | Option exercise | Performance-Based Restricted Stock Units | 733,944 | $0.00 | - | |
| Chintu Patel - Officer | Option exercise | Restricted Stock Units | 92,593 | $0.00 | - | |
| Chintu Patel - Officer | Option exercise | Class A Common Stock | 59,931 footnote F1 | - footnote F2 | - | |
| Chintu Patel - Officer | Tax withholding / forfeiture | Class A Common Stock | 17,112 footnote F3 | $13.31 | $228K | |
| Chintu Patel - Officer | Option exercise | Class A Common Stock | 733,944 | - footnote F4 | - | |
| Chintu Patel - Officer | Tax withholding / forfeiture | Class A Common Stock | 315,885 footnote F5 | $13.31 | $4.20M | |
| Chintu Patel - Officer | Option exercise | Class A Common Stock | 92,593 footnote F1 | - footnote F2 | - | |
| ||||||
| Option exercise | Class A Common Stock | 59,931 footnote F1 | - footnote F2 | - | ||
| Tax withholding / forfeiture | Class A Common Stock | 15,616 footnote F3 | $13.31 | $208K | ||
| Option exercise | Class A Common Stock | 733,944 | - footnote F4 | - | ||
| Tax withholding / forfeiture | Class A Common Stock | 297,537 footnote F5 | $13.31 | $3.96M | ||
| Option exercise | Class A Common Stock | 92,593 footnote F1 | - footnote F2 | - | ||
| Tax withholding / forfeiture | Class A Common Stock | 37,825 footnote F3 | $13.30 | $503K | ||
| Option exercise | Restricted Stock Units | 59,931 | $0.00 | - | ||
| Option exercise | Restricted Stock Units | 92,593 | $0.00 | - | ||
| Option exercise | Performance-Based Restricted Stock Units | 733,944 | $0.00 | - | ||
| ||||||
| Jason B. Daly - Officer | Option exercise | Class A Common Stock | 22,645 footnote F1 | - footnote F2 | - | |
| Jason B. Daly - Officer | Tax withholding / forfeiture | Class A Common Stock | 10,147 footnote F3 | $13.31 | $135K | |
| Jason B. Daly - Officer | Option exercise | Class A Common Stock | 38,226 footnote F1 | - footnote F2 | - | |
| Jason B. Daly - Officer | Tax withholding / forfeiture | Class A Common Stock | 16,598 footnote F3 | $13.31 | $221K | |
| Jason B. Daly - Officer | Option exercise | Class A Common Stock | 24,258 footnote F1 | - footnote F2 | - | |
| Jason B. Daly - Officer | Tax withholding / forfeiture | Class A Common Stock | 10,533 footnote F3 | $13.31 | $140K | |
| Jason B. Daly - Officer | Option exercise | Class A Common Stock | 305,810 | - footnote F4 | - | |
| Jason B. Daly - Officer | Tax withholding / forfeiture | Class A Common Stock | 132,783 footnote F5 | $13.31 | $1.77M | |
| Jason B. Daly - Officer | Option exercise | Class A Common Stock | 35,880 footnote F1 | - footnote F2 | - | |
| Jason B. Daly - Officer | Tax withholding / forfeiture | Class A Common Stock | 15,580 footnote F3 | $13.30 | $207K | |
| Jason B. Daly - Officer | Option exercise | Restricted Stock Units | 22,645 | $0.00 | - | |
| Jason B. Daly - Officer | Option exercise | Restricted Stock Units | 38,226 | $0.00 | - | |
| Jason B. Daly - Officer | Option exercise | Restricted Stock Units | 24,258 | $0.00 | - | |
| Jason B. Daly - Officer | Option exercise | Performance-Based Restricted Stock Units | 305,810 | $0.00 | - | |
| Jason B. Daly - Officer | Option exercise | Restricted Stock Units | 35,880 | $0.00 | - | |
| ||||||
| Tax withholding / forfeiture | Class A Common Stock | 24,251 footnote F3 | $13.31 | $323K | ||
| Option exercise | Class A Common Stock | 28,538 footnote F1 | - footnote F2 | - | ||
| Tax withholding / forfeiture | Class A Common Stock | 14,298 footnote F3 | $13.31 | $190K | ||
| Option exercise | Class A Common Stock | 458,716 | - footnote F4 | - | ||
| Tax withholding / forfeiture | Class A Common Stock | 229,817 footnote F5 | $13.31 | $3.06M | ||
| Option exercise | Class A Common Stock | 43,982 footnote F1 | - footnote F2 | - | ||
| Tax withholding / forfeiture | Class A Common Stock | 22,035 footnote F3 | $13.30 | $293K | ||
| Option exercise | Restricted Stock Units | 45,290 | $0.00 | - | ||
| Option exercise | Restricted Stock Units | 57,339 | $0.00 | - | ||
| Option exercise | Restricted Stock Units | 28,538 | $0.00 | - | ||
| Option exercise | Performance-Based Restricted Stock Units | 458,716 | $0.00 | - | ||
| Option exercise | Restricted Stock Units | 49,982 | $0.00 | - | ||
| Option exercise | Class A Common Stock | 45,290 footnote F1 | - footnote F2 | - | ||
| Tax withholding / forfeiture | Class A Common Stock | 16,182 footnote F3 | $13.31 | $215K | ||
| Option exercise | Class A Common Stock | 57,339 footnote F1 | - footnote F2 | - | ||
| ||||||
| Option exercise | Class A Common Stock | 39,252 footnote F1 | - footnote F2 | - | ||
| Option exercise | Restricted Stock Units | 39,252 | $0.00 | - | ||
| Option exercise | Restricted Stock Units | 49,694 | $0.00 | - | ||
| Option exercise | Restricted Stock Units | 24,258 | $0.00 | - | ||
| Option exercise | Performance-Based Restricted Stock Units | 397,554 | $0.00 | - | ||
| Option exercise | Restricted Stock Units | 38,195 | $0.00 | - | ||
| Tax withholding / forfeiture | Class A Common Stock | 19,945 footnote F3 | $13.31 | $265K | ||
| Option exercise | Class A Common Stock | 49,694 footnote F1 | - footnote F2 | - | ||
| Tax withholding / forfeiture | Class A Common Stock | 24,897 footnote F3 | $13.31 | $331K | ||
| Option exercise | Class A Common Stock | 24,258 footnote F1 | - footnote F2 | - | ||
| Tax withholding / forfeiture | Class A Common Stock | 12,154 footnote F3 | $13.31 | $162K | ||
| Option exercise | Class A Common Stock | 397,554 | - footnote F4 | - | ||
| Tax withholding / forfeiture | Class A Common Stock | 199,175 footnote F5 | $13.31 | $2.65M | ||
| Option exercise | Class A Common Stock | 38,195 footnote F1 | - footnote F2 | - | ||
| Tax withholding / forfeiture | Class A Common Stock | 19,136 footnote F3 | $13.30 | $255K | ||
| ||||||
| Nikita Shah - Officer | Option exercise | Class A Common Stock | 36,232 footnote F1 | - footnote F2 | - | |
| Nikita Shah - Officer | Tax withholding / forfeiture | Class A Common Stock | 18,502 footnote F3 | $13.31 | $246K | |
| Nikita Shah - Officer | Option exercise | Class A Common Stock | 45,871 footnote F1 | - footnote F2 | - | |
| Nikita Shah - Officer | Tax withholding / forfeiture | Class A Common Stock | 22,982 footnote F3 | $13.31 | $306K | |
| Nikita Shah - Officer | Option exercise | Class A Common Stock | 23,544 footnote F1 | - footnote F2 | - | |
| Nikita Shah - Officer | Tax withholding / forfeiture | Class A Common Stock | 11,796 footnote F3 | $13.31 | $157K | |
| Nikita Shah - Officer | Option exercise | Class A Common Stock | 366,972 | - footnote F4 | - | |
| Nikita Shah - Officer | Tax withholding / forfeiture | Class A Common Stock | 183,853 footnote F5 | $13.31 | $2.45M | |
| Nikita Shah - Officer | Option exercise | Class A Common Stock | 35,880 footnote F1 | - footnote F2 | - | |
| Nikita Shah - Officer | Tax withholding / forfeiture | Class A Common Stock | 17,976 footnote F3 | $13.30 | $239K | |
| Nikita Shah - Officer | Option exercise | Restricted Stock Units | 36,232 | $0.00 | - | |
| Nikita Shah - Officer | Option exercise | Restricted Stock Units | 45,871 | $0.00 | - | |
| Nikita Shah - Officer | Option exercise | Restricted Stock Units | 23,544 | $0.00 | - | |
| Nikita Shah - Officer | Option exercise | Performance-Based Restricted Stock Units | 366,972 | $0.00 | - | |
| Nikita Shah - Officer | Option exercise | Restricted Stock Units | 35,880 | $0.00 | - | |
| ||||||
| Chintu Patel - Officer | Grant or award | Restricted Stock Units | 190,632 | $0.00 | - | |
| Chintu Patel - Officer | Grant or award | Performance-Based Restricted Stock Units | 354,031 | $0.00 | - | |
Recent AMRX Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| JOHN KIELY | Director | 50,000 | $880K | View on EDGAR | |
| NIKITA SHAH | Officer | 146,403 | $2.56M |
AMRX insider trading FAQ
What is the latest insider trade for AMRX?
Amneal Pharmaceuticals, Inc. (AMRX) had 12 insider filings in the last 90 days, with the most recent on 2026-09-21. The full record for AMRX runs to 51 Form 4 filings, the earliest from 2024-11-19. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying AMRX stock?
No insider purchases of AMRX were filed in the last 90 days.
How many insiders are selling AMRX stock?
4 insider sales of AMRX were filed in the last 90 days, totaling $7.22M.
Where can I see AMRX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects AMRX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - J. Kevin Buchi view on EDGAR
- - J. Kevin Buchi view on EDGAR
- - Andrew S. Boyer view on EDGAR
- - Andrew S. Boyer view on EDGAR
- - John Kiely view on EDGAR
- - Nikita Shah view on EDGAR
- - Jason B. Daly view on EDGAR
- - J. Kevin Buchi view on EDGAR
- - Tushar Bhikhubhai Patel view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where AMRX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow AMRX with a 7-day demo
- AMRX on your watchlist
- Every AMRX Form 4 filing on record
- Up to 3 months of AMRX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive